Related Experiment Video
Updated: Jan 15, 2026

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
Published on: July 8, 2025
Phantosmia and Benzodiazepine Withdrawal: A Case Report
Miki Kiyokawa1, Saige R Fong1, Micaiah C Cape1
1Department of Psychiatry, University of Hawaii, John A. Burns School of Medicine (JABSOM), Honolulu, USA.
None:
Olfactory hallucinations, known as phantosmia, involve the perception of smell without the presence of existing chemical stimuli and are usually described as unpleasant. Other than a single brief mention as one of the symptoms of benzodiazepine withdrawal, olfactory hallucinations are not specifically listed as a symptom of benzodiazepine withdrawal in the common literature. We report the case of an older female with no previous history of psychosis, taking clonazepam for anxiety for five years. She was instructed by her outpatient provider to stop clonazepam before her elective surgery. Due to fear of mixing oxycodone prescribed for postoperative pain, the patient did not resume taking clonazepam during the hospitalization after surgery. No education was provided about benzodiazepine withdrawal or its symptoms. After discharge, she continued to hold clonazepam and started to experience a series of symptoms, such as insomnia, increased sensitivity to smell, and hearing music in her ears. On the day of admission, 14 days after her last clonazepam, she presented with the perception of an unpleasant odor, which she described as "bad" and "evil." Clonazepam was restarted, and all symptoms promptly resolved. To the best of our knowledge, no such case has been reported before. This case illustrates a rare presentation of olfactory hallucinations most likely precipitated by benzodiazepine withdrawal that was completely reversed by restarting the medication. In addition, it emphasizes the importance of providers and patient education regarding safe benzodiazepine discontinuation and raising awareness that olfactory hallucinations may present as a symptom of benzodiazepine withdrawal.
More Related Videos
05:12Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
Related Concept Videos
Anxiolytic Drugs: Benzodiazepines and Buspirone
CNS Depressants: Barbiturates and Benzodiazepines
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Sleepwalking and Sleep Talking
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...